Medtronic (Minneapolis) reported the commercial availability of its Reveal XT Insertable Cardiac Monitor (ICM) in the U.S., along with the nation's first implant of the device. Blair Grubb, MD, a professor of medicine and pediatrics at the University of Toledo Medical Center in Ohio, conducted the procedure. (Medical Device Daily)
There are a number of good cancer tests designed to catch the disease as soon as it shows up, but one company believes it has found a way to detect signs of whole-body cancers long before the disease is even present. GlycoMeds (Phoenix) says its Cancer Test is a broad-scope test that detects conditions within the body that allow cancer cell growth prior to cancer cells being active. (Medical Device Daily)
AdvanDx (Woburn, Massachusetts) reported receiving FDA 510(k) clearance for E. coli/P. aeruginosa PNA FISH to identify Escherichia coli and/or Pseudomonas aeruginosa directly from positive blood cultures. According to the company, the new diagnostic is the first test for identifying E. coli and P. aeruginosa directly from positive blood cultures and the latest addition to AdvanDx's molecular-based PNA FISH diagnostics platform. (Medical Device Daily)
